Wyeth clinical trials

Acquired by Pfizer, Oct 15, 2009 · source ↗

The registry lists 484 studies whose lead sponsor is Wyeth. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 25, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 484. List all 484 → · All Pfizer studies →

• Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)CompletedNCT00300755Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in IndiaCompletedNCT00452790Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin InfectionsCompletedNCT00368537Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With PsoriasisCompletedNCT00563524Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenCompletedNCT00406640Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.CompletedNCT00393471Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant RecipientsCompletedNCT00195429Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant PatientsCompletedNCT00519116Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral NeuropathyTerminatedNCT01050218Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted after Wyeth became part of Pfizer

• Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With SirolimusCompletedNCT00518375Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in TaiwanCompletedNCT00688870Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of AgeTerminatedNCT00759655Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid ArthritisWithdrawnNCT00783536Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00151398Phase 2

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating GAP-486 in Non-sustained Ventricular TachycardiaTerminatedNCT00124891Phase 2

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia PatientsTerminatedNCT00581243Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953CompletedNCT00441987Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Of Remission In Patients Treated For Generalized Anxiety DisorderCompletedNCT01788553

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic ArthritisCompletedNCT00245960Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Immune Response In Children Revaccinated With Pneumococcal Conjugate VaccineCompletedNCT00853749Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic PatientsWithdrawnNCT00781794Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789CompletedNCT00795730Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Effexor XR in Chinese Subjects With Major Depressive DisorderWithdrawnNCT00878748Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling WomenWithdrawnNCT00447863Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective DisorderWithdrawnNCT00892021Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive DisorderCompletedNCT00669110Phase 2

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating TRU-015 in B-Cell Non-Hodgkin's LymphomaTerminatedNCT00521638Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Brompheniramine Maleate Liquid in Children and AdolescentsCompletedNCT00894634Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Chlorpheniramine Maleate Liquid in Children and AdolescentsCompletedNCT00837837Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial CystitisWithdrawnNCT00275379Not applicable

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating ERB-041 With Methotrexate in Rheumatoid ArthritisCompletedNCT00141830Phase 2

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study of PKI-179 Administered Orally to Subjects With Solid TumorsWithdrawnNCT00997360Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted after Wyeth became part of Pfizer

• Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese MalesCompletedNCT00543946Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Single Doses of GAP-134WithdrawnNCT00820521Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male SubjectsCompletedNCT00854009Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple DosesCompletedNCT00909688Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Comparing Blood Levels of ReFacto and Advante in Hemophilia AWithdrawnNCT00168051Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Safety and Tolerability of Inotuzumab Ozogamicin (CMC-544) in Japanese Patients With B-cell Non-Hodgkin's Lymphoma (NHL)CompletedNCT00717925Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate TherapyTerminatedNCT00076206Phase 2

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral SolutionCompletedNCT00367536Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating ERB-041 in Endometriosis in Reproductive-Age WomenCompletedNCT00110487Phase 2

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers DiseaseCompletedNCT00397891Phase 1

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDDCompletedNCT00445679Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• A Study To Evaluate Methods To Evaluate Back PainCompletedNCT01045993Not applicable

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted after Wyeth became part of Pfizer

• Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy InfantsCompletedNCT00474539Phase 3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Feasibility And Safety Study Of rhBMP-2/CPM For Hip FracturesCompletedNCT00384358Phase 2

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial FracturesTerminatedNCT00387686Phase 2/3

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Benzocaine Gel Toothache Dose-Response StudyCompletedNCT00474175Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• A Study of rhBMP-2/CPM in Closed Fractures of the HumerusCompletedNCT00384852Phase 2

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer

• Effects of Etanercept on Nail Psoriasis and Plaque PsoriasisCompletedNCT00581100Phase 4

  Sponsor listed in the registry: Wyeth is now a wholly owned subsidiary of Pfizer · First submitted before Wyeth became part of Pfizer